Retsch-Bogart, George Z <br/><br/>
A phase 2 study of aztreonam lysine for inhalation to treat patients with cystic fibrosis and Pseudomonas aeruginosa infection.  [electronic resource] 

 -  Pediatric pulmonology  Jan 2008 
 - 47-58 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>8755-6863 
<br/><br/><label>Standard No.: </label>10.1002/ppul.20736  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Inhalation<br/>Adolescent<br/>Adult<br/>Anti-Bacterial Agents--administration & dosage<br/>Aztreonam--administration & dosage<br/>Cystic Fibrosis--complications<br/>Double-Blind Method<br/>Female<br/>Forced Expiratory Flow Rates<br/>Humans<br/>Male<br/>Nebulizers and Vaporizers<br/>Pseudomonas Infections--complications<br/>Time Factors<br/>Treatment Outcome